Core Insights - The company reported a revenue of 427.80 million yuan for the first half of 2025, representing a year-on-year increase of 11.91% [1] - The net profit attributable to shareholders decreased to 56.61 million yuan, a decline of 27.67% compared to the previous year [1] - The premium paper packaging business generated a revenue of 280.54 million yuan, showing a year-on-year decrease of 9.52% [1] - The overseas controlled pharmaceutical-related business achieved a revenue of 113.73 million yuan, marking a significant year-on-year growth of 101.13% [1]